Clinical Trial Readouts Of COVID-19 Vaccines, Drugs Due In July

(RTTNews) - The total number of confirmed cases of coronavirus has surpassed 14 million, with over 602,000 recorded deaths, as of this writing, according to Johns Hopkins University. Researchers and drug companies are racing against time not only to develop treatments for COVID-19 but also vaccines that could help stop future pandemics.

According to the WHO database, 23 COVID-19 vaccine candidates have advanced into clinical testing.

U.S.-based Moderna Inc. (MRNA), the first to move its COVID-19 vaccine candidate mRNA-1273 in human trials in March, reported positive interim clinical data from its phase I study in May. A phase II study of the vaccine is underway and phase III study is expected to start this month.

Gam-COVID-Vac, a coronavirus vaccine being developed by Russia's Gamaleya Research Institute of Epidemiology and Microbiology, has entered the final stage of clinical trials. Russia could be the first to roll out a coronavirus vaccine to the general public as early as August, according to TASS, Russia's news agency.

Let's take a look at what's in store for some of the COVID-19 vaccines and drug therapies this month.
See also:
Leave a comment
  • Latest
  • Read
  • Commented
Calendar Content
«    Август 2022    »